Observational Study of a Novel Peri Infusion Regimen on the Infusion Associated Reactions With Alemtuzumab Infusion in Patients With Multiple Sclerosis in a Canadian Clinical Setting.
Clinical trial NCT04633967 · COMPLETED
Trial details
- NCT number
- NCT04633967
- Sponsor
- Maritime Neurology
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-05-15
- Primary completion
- 2020-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.